Saint Kitts and Nevis vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin
Saint Kitts and Nevis
0
in 2021
Saint Vincent and the Grenadines
0
in 2021
Saint Kitts and Nevis rank
146th
Saint Vincent and the Grenadines rank
146th
The number of people with susceptibility test result for rifampicin over time
- Saint Kitts and Nevis
- Saint Vincent and the Grenadines
How they compare
Saint Kitts and Nevis currently reports 0 against 0 in Saint Vincent and the Grenadines, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Saint Kitts and Nevis ahead.
Saint Kitts and Nevis ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 3.33 | 2.33 | Saint Vincent and the Grenadines |
| 2020s | 0.5 | 6.5 | 6 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saint Kitts and Nevis or Saint Vincent and the Grenadines?
- Saint Kitts and Nevis, at 0 against 0 in Saint Vincent and the Grenadines as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saint Kitts and Nevis and Saint Vincent and the Grenadines?
- 0, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Saint Vincent and the Grenadines?
- 5 years are reported by both, from 2017 to 2021.
- How do Saint Kitts and Nevis and Saint Vincent and the Grenadines rank globally for the number of people with susceptibility test result for rifampicin?
- Saint Kitts and Nevis ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.